Comment: A hazard ratio of 1.17 for all-cause mortality is a statistic that shouldn’t be ignored, but unfortunately is. It translates to 45 excess deaths for every 1,000 patients treated. But the most concerning aspect of this data is the graded relationship: the longer the exposure, the higher the risk of death. This dose-response curve […]
🍵Comment: Another study dismantling the dogma that coffee is ‘bad for you.’ On the contrary, the data here shows that ‘morning-type’ drinkers enjoy a statistically significant reduction in both all-cause and cardiovascular mortality compared to non-drinkers. These findings also introduce a vital caveat: the circadian context. The fact that heavy consumption is protective only in […]
The Wonk Debate – Audio Critique & Clinical Commentary: Synthesized Clinical Bottom Line updated 12-15-25 The relationship between iodine intake and thyroid pathology is complex, following a U-shaped curve where both deficiency and excess are detrimental. While correcting iodine deficiency is a public health priority, maintaining intake beyond “adequate” levels confers no additional clinical benefit […]
Comment: This study suggests that the ‘dangers’ of high-dose iodine are likely overstated. For the vast majority of the population the healthy thyroid handles high iodine intake with resilience. The adverse events highlighted here likely represent a failure of supporting cofactors—specifically Selenium and Iron—rather than direct toxicity. These nutrients act as the ‘safety valves’ for […]
Comment: It is ‘common knowledge’ that higher iodine supplementation is dangerous. However this review clearly shows the distinction between the ‘healthy majority’ and the ‘vulnerable minority.’ While most individuals possess a robust capacity to handle high iodine loads (via the Wolff-Chaikoff escape mechanism), the data here is a reminder that doesn’t apply for specific subgroups. […]
Comment: This review convincingly details how excess iodine drives autoimmunity at a molecular level, establishing a strong case for biological plausibility. However, it leaves us with significant uncertainty regarding when this becomes a clinical reality. Because the authors rely on a narrative overview rather than a systematic quantitative synthesis, It remains difficult to determine if […]
Comment: This study shows interesting nuances, and different than what is often reported about it. It shows a clear ‘ceiling effect’ for iodine toxicity. The jump in subclinical pathology occurs as soon as we leave deficiency, with no significant difference in risk between ‘more than adequate’ and ‘excessive’ intake. Importantly, this toxicity appears strictly subclinical; […]
Comment: This is a fascinating review of a complex topic. The key clinical pearl here is the paradoxical finding that treatment-induced hypothyroidism (from TKIs/ICPis) often correlates with a favorable prognosis. It underscores the need to closely monitor thyroid function in these patients—not just as a side effect to be managed, but as a potential prognostic […]
Comment: The argument for a ‘window of opportunity’—where MHT might actually be neuroprotective if timed correctly—is compelling. However I remain cautious about broadly applying this as I tend to always consider the risk side of the equation with synthetic medications. The clinical management of Alzheimer’s disease (AD) prevention has long operated on the assumption that […]
Comment: This study presents a fascinating potential validation of the ‘on-target’ theory regarding lipid lowering and metabolic risk. The fact that genetically mimicking PCSK9 inhibition yields the same small increase in diabetes risk as mimicking statins implies a common downstream pathway—likely intracellular cholesterol accumulation in pancreatic beta cells. This means we should be looking at […]
